SIRT1 and diabetic kidney disease: These findings suggest that WYJDTLF ameliorates podocyte injury through modulation of the JAML/SIRT1 pathway, potentially by restoring lipid homeostasis and improving cellular energy metabolism in diabetic nephropathy.